- Investing Ideas
- Australian Pharmaceuticals & Biotech Pure Equity Growth
Australian Pharmaceuticals & Biotech Pure Equity Growth
Results
2
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$18.59
7D
11.3%
1Y
7.6%
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$18.55
7D
10.7%
1Y
7.5%